Author: CreateSpace Independent Publishing Platform
Publisher: Createspace Independent Publishing Platform
ISBN: 9781722203467
Category :
Languages : en
Pages : 24
Book Description
Combined assessment program review of the White River Junction VA Medical Center, White River Junction, Vermont .
Combined Assessment Program Review of the White River Junction Va Medical Center, White River Junction, Vermont .
Author: CreateSpace Independent Publishing Platform
Publisher: Createspace Independent Publishing Platform
ISBN: 9781722203467
Category :
Languages : en
Pages : 24
Book Description
Combined assessment program review of the White River Junction VA Medical Center, White River Junction, Vermont .
Publisher: Createspace Independent Publishing Platform
ISBN: 9781722203467
Category :
Languages : en
Pages : 24
Book Description
Combined assessment program review of the White River Junction VA Medical Center, White River Junction, Vermont .
Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309310032
Category : Medical
Languages : en
Pages : 123
Book Description
Despite the extensive body of evidence that informs regulatory decisions on pharmaceutical products, significant uncertainties persist, including the underlying variability in human biology, factors associated with the chemistry of a drug, and limitations in the research and clinical trial process itself that might limit the generalizability of results. As a result, regulatory reviewers are consistently required to draw conclusions about a drug's safety and efficacy from imperfect data. Efforts are underway within the drug development community to enhance the evaluation and communication of the benefits and risks associated with pharmaceutical products, aimed at increasing the predictability, transparency, and efficiency of pharmaceutical regulatory decision making. Effectively communicating regulatory decisions necessarily includes explanation of the impact of uncertainty on decision making. On February 12 and May 12, 2014, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held public workshops to advance the development of more systematic and structured approaches to characterize and communicate the sources of uncertainty in the assessment of benefits and risks, and to consider their implications for pharmaceutical regulatory decisions. Workshop presentations and discussions on February 12 were convened to explore the science of identifying and characterizing uncertainty in scientific evidence and approaches to translate uncertainties into decisions that reflect the values of stakeholders. The May 12 workshop presentations and discussions explored tools and approaches to communicating about scientific uncertainties to a range of stakeholders in the drug development process. Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products summarizes the presentation and discussion of both events. This report explores potential analytical and communication approaches and identifies key considerations on their development, evaluation, and incorporation into pharmaceutical benefit- risk assessment throughout the entire drug development lifecycle.
Publisher: National Academies Press
ISBN: 0309310032
Category : Medical
Languages : en
Pages : 123
Book Description
Despite the extensive body of evidence that informs regulatory decisions on pharmaceutical products, significant uncertainties persist, including the underlying variability in human biology, factors associated with the chemistry of a drug, and limitations in the research and clinical trial process itself that might limit the generalizability of results. As a result, regulatory reviewers are consistently required to draw conclusions about a drug's safety and efficacy from imperfect data. Efforts are underway within the drug development community to enhance the evaluation and communication of the benefits and risks associated with pharmaceutical products, aimed at increasing the predictability, transparency, and efficiency of pharmaceutical regulatory decision making. Effectively communicating regulatory decisions necessarily includes explanation of the impact of uncertainty on decision making. On February 12 and May 12, 2014, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held public workshops to advance the development of more systematic and structured approaches to characterize and communicate the sources of uncertainty in the assessment of benefits and risks, and to consider their implications for pharmaceutical regulatory decisions. Workshop presentations and discussions on February 12 were convened to explore the science of identifying and characterizing uncertainty in scientific evidence and approaches to translate uncertainties into decisions that reflect the values of stakeholders. The May 12 workshop presentations and discussions explored tools and approaches to communicating about scientific uncertainties to a range of stakeholders in the drug development process. Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products summarizes the presentation and discussion of both events. This report explores potential analytical and communication approaches and identifies key considerations on their development, evaluation, and incorporation into pharmaceutical benefit- risk assessment throughout the entire drug development lifecycle.
Quality of VA Care
Author: United States. Congress. House. Committee on Veterans' Affairs. Subcommittee on Hospitals and Health Care
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 256
Book Description
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 256
Book Description
Inspector General Semiannual Report
Author: United States. Veterans Administration. Inspector General
Publisher:
ISBN:
Category :
Languages : en
Pages : 96
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 96
Book Description
Semi-annual Report ... of the Inspector General
Author: United States. Veterans Administration. Inspector General
Publisher:
ISBN:
Category :
Languages : en
Pages : 96
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 96
Book Description
VA and Defense health care more information needed to determine if VA can meet an increase in demand for posttraumatic stress disorder services : report to the Ranking Democratic Member, Committee on Veterans' Affairs, House of Representatives.
Author:
Publisher: DIANE Publishing
ISBN: 1428938648
Category :
Languages : en
Pages : 35
Book Description
Publisher: DIANE Publishing
ISBN: 1428938648
Category :
Languages : en
Pages : 35
Book Description
Semi-annual Report of the Inspector General (April 1, 1980 to September 30, 1980)
Author: United States. Veterans Administration. Inspector General
Publisher:
ISBN:
Category :
Languages : en
Pages : 96
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 96
Book Description
Semi-annual Report ... of the Inspector General
Author: United States. Veterans Administration. Inspector General
Publisher:
ISBN:
Category :
Languages : en
Pages : 380
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 380
Book Description
Oversight on Post-traumatic Stress Disorder
Author: United States. Congress. Senate. Committee on Veterans' Affairs
Publisher:
ISBN:
Category : Post-traumatic stress disorder
Languages : en
Pages : 672
Book Description
Publisher:
ISBN:
Category : Post-traumatic stress disorder
Languages : en
Pages : 672
Book Description
Annual Report of the Secretary of Veterans Affairs
Author: United States. Department of Veterans Affairs
Publisher:
ISBN:
Category : Veterans
Languages : en
Pages : 932
Book Description
Publisher:
ISBN:
Category : Veterans
Languages : en
Pages : 932
Book Description